Beauty Health (NASDAQ:SKIN – Get Free Report) and Basel Medical Group (NASDAQ:BMGL – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, profitability, analyst recommendations, valuation and dividends.
Earnings and Valuation
This table compares Beauty Health and Basel Medical Group”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Beauty Health | $300.80 million | 0.48 | -$9.52 million | ($0.20) | -5.65 |
| Basel Medical Group | $8.90 million | 1.57 | -$9.50 million | N/A | N/A |
Institutional & Insider Ownership
93.3% of Beauty Health shares are held by institutional investors. 41.0% of Beauty Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Analyst Recommendations
This is a summary of current recommendations and price targets for Beauty Health and Basel Medical Group, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Beauty Health | 1 | 6 | 1 | 0 | 2.00 |
| Basel Medical Group | 1 | 0 | 0 | 0 | 1.00 |
Beauty Health currently has a consensus price target of $2.42, indicating a potential upside of 114.16%. Given Beauty Health’s stronger consensus rating and higher probable upside, analysts plainly believe Beauty Health is more favorable than Basel Medical Group.
Profitability
This table compares Beauty Health and Basel Medical Group’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Beauty Health | -3.16% | -15.40% | -1.74% |
| Basel Medical Group | N/A | N/A | N/A |
Summary
Beauty Health beats Basel Medical Group on 6 of the 11 factors compared between the two stocks.
About Beauty Health
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.
About Basel Medical Group
Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.
Receive News & Ratings for Beauty Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beauty Health and related companies with MarketBeat.com's FREE daily email newsletter.
